[Retracted] miR ‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma
Mol Med Rep. 2024 May;29(5):86. doi: 10.3892/mmr.2024.13210. Epub 2024 Mar 29.ABSTRACTFollowing the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors ...
Source: Molecular Medicine - March 29, 2024 Category: Molecular Biology Authors: Tao He Peijie Chen Lu Jin Jia Hu Yifan Li Liang Zhou Shangqi Yang Xiangming Mao Yaoting Gui Yun Chen Yongqing Lai Source Type: research
[Retracted] miR ‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma
Mol Med Rep. 2024 May;29(5):86. doi: 10.3892/mmr.2024.13210. Epub 2024 Mar 29.ABSTRACTFollowing the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors ...
Source: Molecular Medicine - March 29, 2024 Category: Molecular Biology Authors: Tao He Peijie Chen Lu Jin Jia Hu Yifan Li Liang Zhou Shangqi Yang Xiangming Mao Yaoting Gui Yun Chen Yongqing Lai Source Type: research
[Retracted] miR ‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma
Mol Med Rep. 2024 May;29(5):86. doi: 10.3892/mmr.2024.13210. Epub 2024 Mar 29.ABSTRACTFollowing the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors ...
Source: Molecular Medicine Reports - March 29, 2024 Category: Molecular Biology Authors: Tao He Peijie Chen Lu Jin Jia Hu Yifan Li Liang Zhou Shangqi Yang Xiangming Mao Yaoting Gui Yun Chen Yongqing Lai Source Type: research
Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
Biomed Res Int. 2024 Mar 20;2024:9838460. doi: 10.1155/2024/9838460. eCollection 2024.ABSTRACT[This retracts the article DOI: 10.1155/2021/9972968.].PMID:38550156 | PMC:PMC10977301 | DOI:10.1155/2024/9838460 (Source: Cell Research)
Source: Cell Research - March 29, 2024 Category: Cytology Authors: BioMed Research International Source Type: research
[Retracted] miR ‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma
Mol Med Rep. 2024 May;29(5):86. doi: 10.3892/mmr.2024.13210. Epub 2024 Mar 29.ABSTRACTFollowing the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors ...
Source: Molecular Medicine Reports - March 29, 2024 Category: Molecular Biology Authors: Tao He Peijie Chen Lu Jin Jia Hu Yifan Li Liang Zhou Shangqi Yang Xiangming Mao Yaoting Gui Yun Chen Yongqing Lai Source Type: research
First-in-Human Phase I Trial of TPST-1120, an inhibitor of PPAR α, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
CONCLUSIONS: TPST-1120 was well tolerated as monotherapy and in combination with nivolumab and the combination showed preliminary evidence of clinical activity in PD-1 inhibitor refractory and immune compromised cancers.PMID:38551394 | DOI:10.1158/2767-9764.CRC-24-0082 (Source: Cell Research)
Source: Cell Research - March 29, 2024 Category: Cytology Authors: Mark Yarchoan John D Powderly Bruno R Bastos Thomas B Karasic Oxana V Crysler Pamela N Munster Meredith A McKean Leisha A Emens Yvonne M Saenger Yasser Ged Robert Stagg Steven Smith Chan C Whiting Anne Moon Peppi Prasit Yonchu Jenkins Nathan Standifer Tho Source Type: research
[Retracted] miR ‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma
Mol Med Rep. 2024 May;29(5):86. doi: 10.3892/mmr.2024.13210. Epub 2024 Mar 29.ABSTRACTFollowing the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors ...
Source: Molecular Medicine Reports - March 29, 2024 Category: Molecular Biology Authors: Tao He Peijie Chen Lu Jin Jia Hu Yifan Li Liang Zhou Shangqi Yang Xiangming Mao Yaoting Gui Yun Chen Yongqing Lai Source Type: research
A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma
CONCLUSIONS: We developed a risk signature constructed based on the five LLPS-related genes and can have a high ability to predict the prognosis of ccRCC patients, further providing a strong support for clinical decision-making.PMID:38546385 | DOI:10.18632/aging.205691 (Source: Aging)
Source: Aging - March 28, 2024 Category: Biomedical Science Authors: Qing Lu Ping Xi Suling Xu Zhicheng Zhang Binbin Gong Ji Liu Qiqi Zhu Ting Sun Shaoxing Zhu Ru Chen Source Type: research
CASC19: An Oncogenic Long Non-coding RNA in Different Cancers
Curr Pharm Des. 2024 Mar 27. doi: 10.2174/0113816128300061240319034243. Online ahead of print.ABSTRACTA 324 bp lncRNA called CASC19 is found on chromosome 8q24.21. Recent research works have revealed that CASC19 is involved in the prognosis of tumors and related to the regulation of the radiation tolerance mechanisms during tumor radiotherapy (RT). This review sheds light on the changes and roles that CASC19 plays in many tumors and diseases, such as nasopharyngeal carcinoma (NPC), cervical cancer, colorectal cancer (CRC), non-small cell lung cancer (NSCLC), clear cell renal cell carcinoma (ccRCC), gastric cancer (GC), pan...
Source: Current Pharmaceutical Design - March 28, 2024 Category: Drugs & Pharmacology Authors: Yinxin Wu Jie Mou Gang Zhou Chengfu Yuan Source Type: research
A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma
CONCLUSIONS: We developed a risk signature constructed based on the five LLPS-related genes and can have a high ability to predict the prognosis of ccRCC patients, further providing a strong support for clinical decision-making.PMID:38546385 | DOI:10.18632/aging.205691 (Source: Aging)
Source: Aging - March 28, 2024 Category: Biomedical Science Authors: Qing Lu Ping Xi Suling Xu Zhicheng Zhang Binbin Gong Ji Liu Qiqi Zhu Ting Sun Shaoxing Zhu Ru Chen Source Type: research
Effect of galectin ‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
ConclusionsHigh galectin-1 indicated therapeutic resistance and shorter PFS of IO/TKI therapy. High galectin-1 also indicated CD8+ T cell dysfunction. High galectin-1 could be applied for patient selection of IO/TKI therapy in RCC. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Jiajun Wang,
Sihong Zhang,
Ying Wang,
Yanjun Zhu,
Xianglai Xu,
Jianming Guo Tags: RESEARCH ARTICLE Source Type: research
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma
Oncogene, Published online: 28 March 2024; doi:10.1038/s41388-024-03013-4Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma (Source: Oncogene)
Source: Oncogene - March 28, 2024 Category: Cancer & Oncology Authors: Shengpan Wu Baojun Wang Hongzhao Li Hanfeng Wang Songliang Du Xing Huang Yang Fan Yu Gao Liangyou Gu Qingbo Huang Jianjun Chen Xu Zhang Yan Huang Xin Ma Source Type: research
Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model
ConclusionOur immunotumoroid model replicated the multicellular nature of the tumor microenvironment sufficiently for preclinical ICI screening. This model could enable valuable insights into the complex interactions between cancer cells, the immune system, and the microenvironment. This is a feasibility study on a small number of cases, and additional studies with larger case numbers are required including correlation with clinical response. (Source: Frontiers in Immunology)
Source: Frontiers in Immunology - March 28, 2024 Category: Allergy & Immunology Source Type: research
